(Q40798478)

23 September 2017

title

IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway (English)

1 reference

23 September 2017

0 references

hepatocellular carcinoma

1 reference

E C Shin

1

1 reference

23 September 2017

J M Ahn

2

1 reference

23 September 2017

C H Kim

3

1 reference

23 September 2017

Y Choi

4

1 reference

23 September 2017

Y S Ahn

5

1 reference

23 September 2017

H Kim

6

1 reference

23 September 2017

S J Kim

7

1 reference

23 September 2017

J H Park

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

International Journal of Cancer

23 September 2017

published in

1 reference

23 September 2017

volume

93

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

262-268

1 reference

The molecular cell biology of interferon-gamma and its receptor

23 September 2017

cites work

1 reference

Modulation of resistance to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines

21 January 2018

1 reference

Apoptosis of colorectal adenocarcinoma (COLO 201) by tumour necrosis factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma), resulting from down-modulation of Bcl-2 expression

21 January 2018

1 reference

Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression

21 January 2018

1 reference

Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line

21 January 2018

1 reference

Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis

21 January 2018

1 reference

Apoptosis by death factor

21 January 2018

1 reference

Transducing signals of life and death

21 January 2018

1 reference

Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

21 January 2018

1 reference

Death receptors: signaling and modulation

21 January 2018

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

21 January 2018

1 reference

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

21 January 2018

1 reference

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

21 January 2018

1 reference

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL

21 January 2018

1 reference

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

21 January 2018

1 reference

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

21 January 2018

1 reference

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

Characterization of cell lines established from human hepatocellular carcinoma

21 January 2018

1 reference

Pyrrolidine dithiocarbamate induces bovine cerebral endothelial cell death by increasing the intracellular zinc level

21 January 2018

1 reference

Expression of Fas-related genes in human hepatocellular carcinomas.

21 January 2018

1 reference

Expression of fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBX) in induction of Fas ligand

21 January 2018

1 reference

TRAIL death pathway expression and induction in thyroid follicular cells

21 January 2018

1 reference

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

21 January 2018

1 reference

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

21 January 2018

1 reference

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases

21 January 2018

1 reference

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

21 January 2018

1 reference

Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas-dependent and Fas-independent pathways

21 January 2018

1 reference

TRAIL: a molecule with multiple receptors and control mechanisms

21 January 2018

1 reference

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

21 January 2018

1 reference

Tumor expression of Fas ligand (CD95L) and the consequences

21 January 2018

1 reference

Functional expression of TRAIL by lymphoid and myeloid tumour cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.1310

1 reference

23 September 2017

1 reference